Monopar Therapeutics (MNPR) Stock Chart & Stock Price History $49.83 -2.06 (-3.97%) As of 01:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Monopar Therapeutics Stock Price Performance 5 Day Performance+7.97%1 Month Performance+100.65%3 Month Performance+205.31%6 Month Performance+2,201.58%Year-To-Date Performance+131.20%1 Year Performance+2,806.57% Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address MNPR Stock Chart for Tuesday, February, 11, 2025 MNPR Chart by TradingView Monopar Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/10/2025$48.46$51.89+7.08%$54.30$47.81103,113 shs$316.53 million02/07/2025$47.11$48.46+2.87%$49.22$46.1659,470 shs$295.70 million02/06/2025$48.77$47.11-3.40%$51.22$43.4481,032 shs$287.37 million02/05/2025$48.00$48.77+1.60%$51.48$45.9572,749 shs$297.50 million02/04/2025$43.55$48.00+10.22%$49.98$41.8380,345 shs$292.80 million02/03/2025$43.94$43.55-0.89%$44.36$38.9080,098 shs$265.74 million01/31/2025$42.50$43.94+3.39%$44.86$38.9096,592 shs$268.03 million01/30/2025$38.80$42.50+9.54%$42.50$37.2073,275 shs$259.34 million01/29/2025$41.82$38.80-7.22%$42.02$34.4188,924 shs$236.68 million01/28/2025$33.52$41.82+24.76%$42.39$34.5060,340 shs$255.10 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/27/2025$41.46$33.52-19.15%$45.27$31.00100,523 shs$204.47 million01/24/2025$39.32$41.46+5.44%$41.94$37.83122,014 shs$252.91 million01/23/2025$33.67$39.32+16.78%$39.99$33.50102,261 shs$239.85 million01/22/2025$31.68$33.67+6.28%$35.00$31.9576,571 shs$205.39 million01/21/2025$28.54$31.68+11.00%$32.52$28.6030,984 shs$193.25 million01/20/2025$28.54$28.54$31.95$26.6768,472 shs$150.69 million01/17/2025$30.48$28.54-6.36%$31.95$26.6768,472 shs$150.63 million01/16/2025$26.91$30.48+13.27%$31.94$26.2563,961 shs$160.93 million01/15/2025$24.98$26.91+7.73%$26.91$24.00104,074 shs$142.03 million01/14/2025$25.69$24.98-2.76%$26.00$24.3154,086 shs$131.84 million01/13/2025$25.35$25.69+1.34%$26.00$25.1537,246 shs$135.59 million01/10/2025$24.46$25.35+3.64%$26.52$24.3038,652 shs$133.80 million Related Companies Zymeworks Stock Price Chart Collegium Pharmaceutical Stock Price Chart Cogent Biosciences Stock Price Chart 89bio Stock Price Chart Intellia Therapeutics Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Replimune Group Stock Price Chart GH Research Stock Price Chart Poseida Therapeutics Stock Price Chart ArriVent BioPharma Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 2/11/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredTrump’s “Shock and Awe” Executive OrderPresident Trump has already launched a "shock and awe" flurry of new Executive Orders... He's withdrawn fro...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
